Suppr超能文献

米曲霉发酵大豆可提高胰岛素敏感性和胰岛素促泌活性。

Soybean fermentation with Bacillus licheniformis increases insulin sensitizing and insulinotropic activity.

机构信息

Division of Food Certificate Center, Korean Food Research Institutes, Sungnam, South Korea.

出版信息

Food Funct. 2013 Nov;4(11):1675-84. doi: 10.1039/c3fo60198f.

Abstract

Traditionally fermented soybeans (chungkookjang; TFC) may have potent anti-diabetic activity, depending on the ambient microorganisms and conditions. We hypothesized that one of the major Bacillus species in TFC contributes to the anti-diabetic activity and could be used to standardize a highly functional TFC. We tested the hypothesis by using cell-based studies to evaluate insulin sensitizing and insulinotropic action of chungkookjangs fermented with various Bacillus spp. and fermentation periods. The 70% methanol and water extracts of chungkookjang fermented with Bacillus licheniformis (BL) for 48 h contained similar profiles of isoflavonoids and peptides to methanol and water extracts of TFC with potent anti-diabetic activity. Water extracts (mainly containing peptides) of TFC and BL fermented for 48 h and 72 h had a better insulin sensitizing action via activating peroxisome proliferator-activated receptor-γ (PPAR-γ) and increased the expression of PPAR-γ in 3T3-L1 adipocytes better than unfermented cooked soybeans (CSB). The 70% methanol extracts (predominantly isoflavone aglycones) of BL fermented for 48 h and 72 h improved glucose-stimulated insulin secretion and protected β-cell viability better than CSB in insulinoma cells, and the improvement by BL was similar to TFC. In conclusion, the BL water extract fermented for 48 h exhibited equal insulin sensitization as TFC and BL methanol extract exerted similar insulinotropic actions to those of TFC. B. licheniformis may be one of the major microorganisms responsible for anti-diabetic actions of chungkookjang. It is important to make chungkookjang that retains the anti-diabetic properties of the most efficacious traditional chungkookjang using a standardized method.

摘要

传统发酵大豆(肠内常康,TFC)可能具有强大的抗糖尿病活性,具体取决于环境中的微生物和条件。我们假设 TFC 中的主要芽孢杆菌之一有助于抗糖尿病活性,并且可以用于标准化高功能性 TFC。我们通过使用基于细胞的研究来评估用各种芽孢杆菌和发酵时间发酵的肠内常康的胰岛素增敏和胰岛素分泌作用来检验该假设。与具有强大抗糖尿病活性的 TFC 的甲醇和水提取物相似,用地衣芽孢杆菌(BL)发酵 48 小时的肠内常康的 70%甲醇和水提取物含有类似的异黄酮和肽谱。TFC 和 BL 发酵 48 小时和 72 小时的水提取物(主要含有肽)通过激活过氧化物酶体增殖物激活受体-γ(PPAR-γ)并在 3T3-L1 脂肪细胞中更好地增加 PPAR-γ的表达,具有更好的胰岛素增敏作用,优于未发酵的熟大豆(CSB)。用 BL 发酵 48 小时和 72 小时的 70%甲醇提取物(主要是异黄酮苷元)改善了葡萄糖刺激的胰岛素分泌,并在胰岛素瘤细胞中更好地保护β细胞活力,优于 CSB,BL 的改善作用与 TFC 相似。总之,BL 水提取物发酵 48 小时表现出与 TFC 相等的胰岛素增敏作用,而 BL 甲醇提取物对胰岛素分泌的作用与 TFC 相似。地衣芽孢杆菌可能是 TFC 抗糖尿病作用的主要微生物之一。使用标准化方法制作保留最有效传统 TFC 抗糖尿病特性的肠内常康非常重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验